All publications
Main content
2024
Gjelberg HK, Helgeland L, Tsykunova G,ÌýReikvam H.Expert Rev Hematol. 2024 Sep;17(9):543-546. doi: 10.1080/17474086.2024.2383395. Epub 2024 Jul 27.PMID:Ìý39037042Ìý
Ìý
Reikvam H, Dillon R.Expert Rev Hematol. 2024 Apr-May;17(4-5):103-106. doi: 10.1080/17474086.2024.2347303. Epub 2024 May 3.PMID:Ìý38654593
Ìý
Bruserud Ø, Selheim F, Hernandez-Valladares M,ÌýReikvam H.Int J Mol Sci. 2024 Jun 8;25(12):6356. doi: 10.3390/ijms25126356.PMID:Ìý38928061Ìý
Ha TQ, Andresen V, Erikstein BS, Popa M, Gullaksen SE,ÌýReikvam H, McCormack E, Gjertsen BT.Br J Haematol. 2024 Nov 24. doi: 10.1111/bjh.19872. Online ahead of print.PMID:Ìý39582120
Ìý
Ingebrigtsen A, Saeed S, Larsen TH,ÌýReikvam H.Scand J Clin Lab Invest. 2024 May;84(3):193-201. doi: 10.1080/00365513.2024.2346908. Epub 2024 May 6.PMID:Ìý38709651
Ìý
Sørvoll IH, Lægreid IJ, Sollid T, Ahlen MT, Johansen S,ÌýReikvam H.Mediterr J Hematol Infect Dis. 2024 Jul 1;16(1):e2024057. doi: 10.4084/MJHID.2024.057. eCollection 2024.PMID:Ìý38984091Ìý
Ìý
Hemsing AL, Førde JL,ÌýReikvam H, Herfindal L.Transl Oncol. 2024 Feb;40:101876. doi: 10.1016/j.tranon.2024.101876. Epub 2024 Jan 6.PMID:Ìý38185059Ìý
Ìý
Selheim F, Aasebø E,ÌýReikvam H, Bruserud Ø, Hernandez-Valladares M.Int J Mol Sci. 2024 May 7;25(10):5080. doi: 10.3390/ijms25105080.PMID:Ìý38791118Ìý
Ìý
Sefland Ø, Gullaksen SE, Omsland M,ÌýReikvam H, Galteland E, Tran HTT, Spetalen S, Singh SK, Van Zeeburg HJT, Van De Loosdrecht AA, Gjertsen BT.Cytometry B Clin Cytom. 2024 Nov;106(6):485-496. doi: 10.1002/cyto.b.22197. Epub 2024 Jul 30.PMID:Ìý39078053
Saeed N, Taule EM, Vetti N, Saeed S, Leirgul E,ÌýReikvam H.Tidsskr Nor Laegeforen. 2024 May 16;144(7). doi: 10.4045/tidsskr.23.0742. Print 2024 Jun 4.PMID:Ìý38832610Ìý
Ìý
Ìý
2023
Mosevoll KA, Hansen BA, Gundersen IM, Reikvam H, Bruserud Ø, Bruserud Ø, Wendelbo Ø.Metabolites. 2022 Dec 29;13(1):52. doi: 10.3390/metabo13010052.PMID:Ìý36676977
Cacic D, Hervig T, Reikvam H.Expert Opin Drug Deliv. 2023 May;20(5):673-688. doi: 10.1080/17425247.2023.2217378. Epub 2023 May 26.PMID:Ìý37212640ÌýReview.
Reikvam H.Tidsskr Nor Laegeforen. 2023 Mar 13;143(4). doi: 10.4045/tidsskr.23.0083. Print 2023 Mar 14.PMID:Ìý36919289
Fauchald T, Blomberg B, Reikvam H.J Clin Med. 2023 Aug 18;12(16):5366. doi: 10.3390/jcm12165366.PMID:Ìý37629407Ìý
Reikvam H.Expert Rev Hematol. 2023 May;16(5):317-323. doi: 10.1080/17474086.2023.2202849. Epub 2023 Apr 17.PMID:Ìý37066885
Bruserud Ø, Reikvam H.Cancers (Basel). 2023 Jul 21;15(14):3711. doi: 10.3390/cancers15143711.PMID:Ìý37509370Ìý
Bruserud Ø, Mosevoll KA, Bruserud Ø, Reikvam H, Wendelbo Ø.Cells. 2023 Mar 24;12(7):1003. doi: 10.3390/cells12071003.PMID:Ìý37048076Ìý
Austestad J, Madland TM, Sandnes M, Haslerud TM, Benneche A, Reikvam H.Case Rep Hematol. 2023 Feb 25;2023:6551544. doi: 10.1155/2023/6551544. eCollection 2023.PMID:Ìý36879894
Reikvam H, Hetland G, Ezligini F, Dorsch K, Omert L, Dunham A, Almeland SK.Transfus Apher Sci. 2023 Jun 22:103755. doi: 10.1016/j.transci.2023.103755. Online ahead of print.PMID:Ìý37423867
Erikstein BS, Ahmed AB, Forthun RB, Leh F, Gjertsen BT, Reikvam H.J Hematol. 2023 Apr;12(2):92-99. doi: 10.14740/jh1107. Epub 2023 Apr 30.PMID:Ìý37187497
Ìý
Lellahi SM, Azeem W, Hua Y, Gabriel B, Paulsen Rye K, Reikvam H, Kalland KH.Front Immunol. 2023 Jan 12;13:1058963. doi: 10.3389/fimmu.2022.1058963. eCollection 2022.PMID:Ìý36713392
Reikvam H, Bruserud Ø, Hatfield KJ.Transplant Cell Ther. 2023 Jun;29(6):375.e1-375.e14. doi: 10.1016/j.jtct.2023.03.020. Epub 2023 Mar 24.PMID:Ìý36966869
Mosevoll KA, Hansen BA, Gundersen IM, Reikvam H, Bruserud Ø, Bruserud Ø, Wendelbo Ø.Biomolecules. 2023 Jan 24;13(2):223. doi: 10.3390/biom13020223.PMID:Ìý36830594Ìý
Lilleskare S, Vorland M, Vo AK, Aarsand AK, Reikvam H.Scand J Clin Lab Invest. 2023 Feb;83(1):3-7. doi: 10.1080/00365513.2022.2150984. Epub 2022 Dec 7.PMID:Ìý36476017
Sandnes M, Helgeland L, Johansen S, Reikvam H.Tidsskr Nor Laegeforen. 2023 Oct 23;143(15). doi: 10.4045/tidsskr.23.0022. Print 2023 Oct 24.PMID:Ìý37874056
Limi DC, Reikvam H.Expert Opin Pharmacother. 2023 Oct 12:1-4. doi: 10.1080/14656566.2023.2269086. Online ahead of print.PMID:Ìý37823599Ìý
Cacic D, Hervig T, Reikvam H.Expert Opin Drug Deliv. 2023 May;20(5):673-688. doi: 10.1080/17425247.2023.2217378. Epub 2023 May 26.PMID:Ìý37212640Ìý
Solberg A, Reikvam H.Life (Basel). 2023 Oct 2;13(10):2007. doi: 10.3390/life13102007.PMID:Ìý37895389
Gjelberg HK, Helgeland L, Liseth K, Micci F, Sandnes M, Russnes HG, Reikvam H.Curr Oncol. 2023 Nov 18;30(11):10007-10018. doi: 10.3390/curroncol30110727.PMID:Ìý37999147Ìý
Bartaula-Brevik S, Leitch C, Hernandez-Valladares M, Aasebø E, Berven FS, Selheim F, Brenner AK, Rye KP, Hagen M, Reikvam H, McCormack E, Bruserud Ø, Tvedt THA.J Clin Med. 2023 Aug 25;12(17):5546. doi: 10.3390/jcm12175546.PMID:Ìý37685612
Anette Lodvir Hemsing, Jan-Lukas Førde, Kristin Paulsen Rye, HÃ¥konÌýReikvam, Lars Herfindal
Hemasphere.Ìý2023 Aug;Ìý7(Suppl ): e9915813.ÌýPublished online 2023 Aug 8.Ìýdoi:Ìý10.1097/01.HS9.0000974012.99158.13
PMCID:ÌýPMC10430263
H.ÌýReikvam, G. Hetland, F. Ezligini, K. Dorsch, A. Dunham, L. Omert, S. Almeland
Hemasphere.Ìý2023 Apr;Ìý7(Suppl ): 41.ÌýPublished online 2023 Apr 10.Ìýdoi:Ìý10.1097/01.HS9.0000928440.72522.5d
PMCID:ÌýPMC10112628
Ìý
Ìý
Ìý
Ìý
2022
Holmemo HD, Reikvam H.Tidsskr Nor Laegeforen. 2021 Dec 22;141(1). doi: 10.4045/tidsskr.21.0695. Print 2022 Jan 11. PMID:Ìý35026091
Ìý
Raaheim OF, Raaheim DF, Reikvam H, Kvernenes M.Tidsskr Nor Laegeforen. 2022 Aug 12;142(11). doi: 10.4045/tidsskr.22.0337. Print 2022 Aug 16. PMID:Ìý35997188
Ìý
Sandnes M, Reikvam H.Tidsskr Nor Laegeforen. 2022 Jun 7;142(9). doi: 10.4045/tidsskr.22.0026. Print 2022 Jun 14 PMID:Ìý3569955
Ìý
Johansen S, Gjelberg HK, Reikvam H.EJHaem. 2022 Apr 8;3(2):563-564. doi: 10.1002/jha2.437. eCollection 2022 May PMID:Ìý35846062
Ìý
Johansen S, Laegreid IJ, Ernstsen SL, Azrakhsh NA, Kittang AO, LindÃ¥s R, Gjertsen BT, Vetti N, Mørtberg TV, Sørvoll IH, Holme PA, Ahlen MT, Reikvam H.J Thromb Haemost. 2022 Mar;20(3):700-704. doi: 10.1111/jth.15604. Epub 2021 Dec 7. PMID:Ìý34817130
Ìý
Reikvam H, Hemsing AL, Hernandez-Valladares M, Birkeland E.Expert Rev Proteomics. 2022 Feb;19(2):73-76. doi: 10.1080/14789450.2022.2067530. Epub 2022 Apr 22. PMID:Ìý35436165
Ìý
Reikvam H, Vo AK, Johansen S, Hemsing AL, Solheim MH, Mosevoll KA, Tvedt THA, Hatfield KJ.Blood Adv. 2022 Sep 27;6(18):5295-5306. doi: 10.1182/bloodadvances.2021005930. PMID:Ìý35443023
Ìý
Melve GK, Sandnes M, Reikvam H.Expert Rev Hematol. 2022 Jan;15(1):1-4. doi: 10.1080/17474086.2022.2022470. Epub 2022 Jan 6. PMID:Ìý34949139
Ìý
Rolsdorph LÃ…, Mosevoll KA, Reikvam H.Expert Rev Hematol. 2022 Aug;15(8):667-670. doi: 10.1080/17474086.2022.2100341. Epub 2022 Jul 17. PMID:Ìý35819263
Ìý
Kanack AJ, Laegreid IJ, Johansen S, Reikvam H, Ahlen MT, Padmanabhan A.Am J Hematol. 2022 Oct;97(10):E363-E364. doi: 10.1002/ajh.26659. Epub 2022 Aug 3. PMID:Ìý35834243
Ìý
Vo AK, Hervig T, Reikvam H.Expert Opin Investig Drugs. 2022 Sep;31(9):881-884. doi: 10.1080/13543784.2022.2113055. PMID:Ìý35975626
Ìý
Reikvam H, Hatfield KJ, Wendelbo Ø, Lindås R, Lassalle P, Bruserud Ø.Biomolecules. 2022 Mar 24;12(4):492. doi: 10.3390/biom12040492.
Ìý
Reikvam H, Hatfield KJ, Wendelbo Ø, LindÃ¥s R, Lassalle P, Bruserud Ø.Biomolecules. 2022 Mar 24;12(4):492. doi: 10.3390/biom12040492. PMID:Ìý35454082
Ìý
Thunestvedt LMØ, Helgeland L, Bachmann IM, Karlsdottir Ã…, Haslerud TM, Reikvam H.Curr Oncol. 2022 Mar 23;29(4):2193-2198. doi: 10.3390/curroncol29040178. PMID:Ìý35448152
Ìý
Johansen S, KrÃ¥kenes J, Vedeler CA, Storstein AM, Reikvam H.Case Reports Immunol. 2022 Sep 10;2022:4174755. doi: 10.1155/2022/4174755. eCollection 2022 PMID:Ìý36124252
Ìý
Hemsing AL, Rye KP, Hatfield KJ, Reikvam H.Biomedicines. 2022 Aug 4;10(8):1881. doi: 10.3390/biomedicines10081881. PMID:Ìý36009428
Ìý
Hatfield KJ, Bruserud Ø, Reikvam H.Cancers (Basel). 2022 Jun 13;14(12):2910. doi: 10.3390/cancers14122910. PMID:Ìý35740576
Ìý
Bruserud Ø, Reikvam H, Brenner AK.Molecules. 2022 Jan 23;27(3):735. doi: 10.3390/molecules27030735. PMID:Ìý35163998
Ìý
Rolsdorph LÃ…, Mosevoll KA, Helgeland L, Reikvam H.Front Med (Lausanne). 2022 Apr 19;9:819465. doi: 10.3389/fmed.2022.819465. eCollection 2022. PMID:Ìý35514747
Ìý
Kvinge AD, Kvammen T, Miletic H, Bindoff LA, Reikvam H.Curr Oncol. 2022 Nov 3;29(11):8415-8430. doi: 10.3390/curroncol29110663. PMID:Ìý36354723
Ìý
Johansen S, Blomberg B, Vo AK, Wendelbo Ø, Reikvam H.Cytotherapy. 2022 Dec;24(12):1190-1194. doi: 10.1016/j.jcyt.2022.08.006. Epub 2022 Sep 20. PMID:Ìý36151003
Ìý
Helland HK, Tylleskär T, Kvernenes M, Reikvam H.Healthcare (Basel). 2022 Jan 17;10(1):170. doi: 10.3390/healthcare10010170. PMID:Ìý35052333
Ìý
Lilleskare S, Vorland M, Vo AK, Aarsand AK, Reikvam H.Scand J Clin Lab Invest. 2022 Dec 7:1-5. doi: 10.1080/00365513.2022.2150984. Online ahead of print.PMID:Ìý36476017
Ìý
BrattÃ¥s MK, Hemsing AL, Rye KP, Hatfield KJ, Reikvam H.Int J Mol Sci. 2022 Nov 25;23(23):14706. doi: 10.3390/ijms232314706.PMID:Ìý36499034Ìý
Ìý
Vinnes EW, Hemsing AL.Tidsskr Nor Laegeforen. 2022 Nov 7;142(16). doi: 10.4045/tidsskr.22.0546. Print 2022 Nov 8.PMID:Ìý36345642Ìý
Ìý
Ìý
2021
Bruserud Ø, Mosevoll KA, Kristoffersen E, Kvåle R, Reikvam H.Tidsskr Nor Laegeforen. 2021 Jan 11
Reikvam H, Hemsing AL, Smith C.Expert Rev Anticancer Ther. 2021 Jan;21
Ìý
Sandnes M, Ulvik RJ, Vorland M, Reikvam H.J Clin Med. 2021 May 7
Ìý
Johansen S, Laegreid IJ, Ernstsen SL, Azrakhsh NA, Kittang AO, Lindås R, Gjertsen BT, Vetti N, Mørtberg TV, Sørvoll IH, Holme PA, Ahlen MT, Reikvam H.J Thromb Haemost. 2021 Nov 24
Ìý
Wiese-Hansen H, Leh F, Lodvir Hemsing A, Reikvam H.J Clin Med. 2021 Apr
Hervig T, Tvedt THA, Knoop T, Sandnes M, Reikvam H.Tidsskr Nor Laegeforen. 2021 Nov Ìý
Ìý
Tvedt THA, Vo AK, Bruserud Ø, Reikvam H.J Clin Med. 2021 Nov 6
Ìý
Storhaug KØ, Skutlaberg DH, Hansen BA, Reikvam H, Wendelbo Ø.Antibiotics (Basel). 2021 Mar 19
Ìý
Bruserud Ø, Tvedt THA, Ahmed AB, Vintermyr OK, Hervig T, Guttormsen AB, Reikvam H.Case Rep Crit Care. 2021 Mar 8
Ìý
Bruserud Ø, Tsykunova G, Hernandez-Valladares M, Reikvam H, Tvedt THA.Pharmaceuticals (Basel). 2021 May 2
Ìý
Cacic D, Reikvam H, Nordgård O, Meyer P, Hervig T.Cancers (Basel). 2021 Apr 14
Ìý
Steinfeld PF, Knoop T, Trovik LH, Gjelberg HK, Haslerud TM, Reikvam H.Clin Pract. 2021 Jul 22
Ìý
Sandnes M, Vorland M, Ulvik RJ, Reikvam H.Genes (Basel). 2021 Jul 28
Ìý
Ìý
Hatfield KJ, Grønningsaeter IS, Reikvam H.Curr Med Res Opin. 2021 Dec
Ìý
Ìý
Grønningsæter IS, Reikvam H, Aasebø E, Bartaula-Brevik S, Hernandez-Valladares M, Selheim F, Berven FS, Tvedt TH, Bruserud Ø, Hatfield KJ.J Pers Med. 2021 Aug
Ìý
Aasebø E, Brenner AK, Hernandez-Valladares M, Birkeland E, Mjaavatten O, Reikvam H, Selheim F, Berven FS, Bruserud Ø.Diseases. 2021 Oct 16
Ìý
Hernandez-Valladares M, Wangen R, Aasebø E, Reikvam H, Berven FS, Selheim F, Bruserud Ø.Cancers (Basel). 2021 Apr 29
Ìý
Haaland I, Hjelle SM, Reikvam H, Sulen A, Ryningen A, McCormack E, Bruserud Ø, Gjertsen BT.Cells. 2021 Apr 7
Ìý
Hemsing AL, Gjertsen BT, Spetalen S, Helgeland L, Reikvam H.SAGE Open Med Case Rep. 2021 Jan 22
Ìý
ÌýÌýFuture perspective: precision medicine to improve treatment results in the settings of allogenic stem cell transplantation for acute myelogenous leukemia, Reikvam H, Johansen S, Koenecke C. Expert Review of Precision Medicine and Drug DevelopmentÌýMarch 2021 6(2):1-5
Ìý
Surgical Treatment of Severe Bowel Obstruction as a Rare Complication Following Allogenic Hematopoietic Stem Cell Transplantation.ÌýÌýÌýReikvam H, Tvedt THA, Johansen, S, Aase Setran H, Havre RF.ÌýTransplantologyÌý2020,Ìý1, 102-110.
Ìý
2020
Aasebø E, Berven FS, Hovland R, Døskeland SO, Bruserud Ø, Selheim F, Hernandez-Valladares M. Cancers (Basel). 2020 Jun 4;12(6):1466. doi: 10.3390/cancers12061466.
Ìý
Nepstad I, Hatfield KJ, Grønningsæter IS, Reikvam H. Int J Mol Sci. 2020 Apr 21;21(8):2907. doi: 10.3390/ijms21082907.
Ìý
Ìý
Aasebø E, Berven FS, Bartaula-Brevik S, Stokowy T, Hovland R, Vaudel M, Døskeland SO, McCormack E, Batth TS, Olsen JV, Bruserud Ø, Selheim F, Hernandez-Valladares M. Cancers (Basel). 2020 Mar 17;12(3):709. doi: 10.3390/cancers12030709.
Ìý
Tvedt THA, Skaarud KJ, Tjønnfjord GE, Gedde-Dahl T, Iversen PO, Bruserud Ø. Biol Blood Marrow Transplant. 2020 Feb;26(2):380-391. doi: 10.1016/j.bbmt.2019.10.005. Epub 2019 Oct 14.
Ìý
Ìý
Rundgren IM, Ryningen A, Anderson Tvedt TH, Bruserud Ø, Ersvær E. Molecules. 2020 Jan 16;25(2):367. doi: 10.3390/molecules25020367.
Ìý
Hansen BA, Wendelbo Ø, Bruserud Ø, Hemsing AL, Mosevoll KA, Reikvam H. Mediterr J Hematol Infect Dis. 2020 Jan 1;12(1):e2020009. doi: 10.4084/MJHID.2020.009. eCollection 2020.
Ìý
Ìý
Reikvam DH, Meyer-Myklestad MH, Trøseid M, Stiksrud B. Curr Opin Infect Dis. 2020 Feb;33(1):34-43. doi: 10.1097/QCO.0000000000000612.
Ìý
Ìý
Benneche A, Sandnes M, Bakke Ã…, Reikvam H. Tidsskr Nor Laegeforen. 2020 Nov 9;140(16). doi: 10.4045/tidsskr.20.0255. Print 2020 Nov 10.
Ìý
Ìý
Grønningsæter IS, Reikvam H, Aasebø E, Bartaula-Brevik S, Tvedt TH, Bruserud Ø, Hatfield KJ. Cells. 2020 May 7;9(5):1155. doi: 10.3390/cells9051155.
Ìý
Reikvam H, Hemsing AL, Smith C. Expert Rev Anticancer Ther. 2020 Oct 25:1-4. doi: 10.1080/14737140.2021.1838901.
Ìý
Kvåle R, Azrakhsh NA, Mohn KG, Aanerud M, Guttormsen AB, Reikvam H. Tidsskr Nor Laegeforen. 2020 Jun 17;140(11). doi: 10.4045/tidsskr.20.0440.
Ìý
Reikvam H. Cells. 2020 Jul 12;9(7):1677. doi: 10.3390/cells9071677.
Ìý
Trovik LH, Sandnes M, Blomberg B, Holmaas G, Ahmed AB, Tvedt THA, Vintermyr O, Reikvam H. J Med Case Rep. 2020 Nov 11;14(1):217. doi: 10.1186/s13256-020-02555-x.
Ìý
Bruserud Ø, Wendelbo Ø, Vetti N, Goplen FK, Johansen S, Reikvam H. Clin Pract. 2020 Jun 10;10(2):1214. doi: 10.4081/cp.2020.1214. eCollection 2020 May 19.
Ìý
Vo AK, Kollsete Gjelberg H, Hovland R, Lindstad Brattås MK, Bruserud Ø, Reikvam H. Case Rep Hematol. 2020 Jan 20;2020:1262038. doi: 10.1155/2020/1262038. eCollection 2020.
Ìý
Vo AK, Reikvam H, Midtbø H, Wirsching JL, Bruserud Ø, Wendelbo Ø. Case Rep Anesthesiol. 2020 Oct 15;2020:4219616. doi: 10.1155/2020/4219616. eCollection 2020.
Ìý
Bruserud Ø, Engesæter IØ, Mjelle KE, Kristensen F, Wendelbo Ø. Tidsskr Nor Laegeforen. 2020 Sep 11;140(13). doi: 10.4045/tidsskr.20.0382. Print 2020 Sep 29.
Ìý
Hernandez-Valladares M, Bruserud Ø, Selheim F. Int J Mol Sci. 2020 Sep 17;21(18):6830. doi: 10.3390/ijms21186830.
Ìý
Bruserud Ø, Aarstad HH, Tvedt THA. Cancers (Basel). 2020 Jul 19;12(7):1966. doi: 10.3390/cancers12071966.
Ìý
Bruserud Ø, Wendelbo Ø, Vetti N, Goplen FK, Johansen S, Reikvam H. Clin Pract. 2020 Jun 10;10(2):1214. doi: 10.4081/cp.2020.1214. eCollection 2020 May 19.
Ìý
Gudbrandsdottir G, Aarstad HH, Bostad L, Hjelle KM, Aarstad HJ, Bruserud Ø, Tvedt THA, Beisland C. Cancer Immunol Immunother. 2020 Jul 3. doi: 10.1007/s00262-020-02655-z. Online ahead of print
Ìý
Ìý
Rundgren IM, Ersvær E, Ahmed AB, Ryningen A, Bruserud Ø. Medicina (Kaunas). 2020 Jan 18;56(1):36. doi: 10.3390/medicina56010036.
Ìý
Aarstad HH, Guðbrandsdottir G, Hjelle KM, Bostad L, Bruserud Ø, Tvedt THA, Beisland C. Cancers (Basel). 2020 Jul 19;12(7):1961. doi: 10.3390/cancers12071961.
Ìý
Aarstad HH, Moe SEE, Bruserud Ø, Lybak S, Aarstad HJ, Tvedt THA. Biomedicines. 2020 Oct 14;8(10):418. doi: 10.3390/biomedicines8100418.
Ìý
Vo AK, Reikvam H, Midtbø H, Wirsching JL, Bruserud Ø, Wendelbo Ø. Case Rep Anesthesiol. 2020 Oct 15;2020:4219616. doi: 10.1155/2020/4219616. eCollection 2020.
Ìý
Berentsen S, Barcellini W, D'Sa S, Randen U, Tvedt THA, Fattizzo B, Haukås E, Kell M, Brudevold R, Dahm AEA, Dalgaard J, Frøen H, Hallstensen RF, Jæger PH, Hjorth-Hansen H, Małecka A, Oksman M, Rolke J, Sekhar M, Sørbø JH, Tjønnfjord E, Tsykunova G, Tjønnfjord GE. Blood. 2020 Jul 23;136(4):480-488. doi: 10.1182/blood.2020005674.
Ìý
Michel M, Ruggeri M, Gonzalez-Lopez TJ, Alkindi SS, Cheze S, Ghanima W, Tvedt THA, Ebbo M, Terriou L, Bussel JB, Godeau B. Blood. 2020 Aug 19:blood.2020007594. doi: 10.1182/blood.2020007594.
Ìý
Ìý
Ìý
2019
2019 Nov 8;20(1):39. doi: 10.1186/s12865-019-0323-y.
1,2, 1, 3, 1, 4,5.
Ìý
2019 Oct 10;8(10). pii: E1229. doi: 10.3390/cells8101229.
1,2, 3, 4,5, 6,7, 8,9.
Ìý
2019 Jul 11;11(7). pii: E973. doi: 10.3390/cancers11070973.
1,2, 3,4.
Ìý
2019 Jul 4;8(7). pii: E970. doi: 10.3390/jcm8070970.
1,2, 3, 4, 3, 4, 4, 5,6, 3,4.
Ìý
2019 Jul;145(7):1729-1749. doi: 10.1007/s00432-019-02931-1. Epub 2019 May 20.
1, 2, 1, 1, 3, 2,4, 1,2, 5,6.
Ìý
2019 Jun 19;4:20. doi: 10.1038/s41392-019-0050-0. eCollection 2019.
1, 1,2, 1, 1,3, 1,3, 1, 1, 3, 3, 1,4, 1,4.
Ìý
2019 Apr 26;139(8). doi: 10.4045/tidsskr.18.0775. Print 2019 May 7.
[Article in Norwegian]
, , , , .
2019 Mar 27:1-10. doi: 10.1080/13543784.2019.1597052. [Epub ahead of print]
1, 2, 2, 2,3.
Ìý
2019 Mar 24. doi: 10.2174/0929867326666190325095853. [Epub ahead of print]
1, 2.
Ìý
2019 Mar;18(3):567-578. doi: 10.1158/1535-7163.MCT-17-1234. Epub 2019 Jan 24.
1,2, 1, 3, 3, 4, 5, 6, 4, 7, 4, 8.
Ìý
2019 Feb;12(2):119-128. doi: 10.1080/17474086.2019.1570126. Epub 2019 Jan 28.
1, 1,2.
Ìý
2019 Jan 10;11(1). pii: E73. doi: 10.3390/cancers11010073.
1,2, 3,4, 5,6, 7, 8, 9,10, 11, 12,13.
2018
2018 Dec;20(12):1175-1186. doi: 10.1016/j.neo.2018.09.007. Epub 2018 Oct 23.
1, 2.
Ìý
2018 Dec 20;7(1). pii: E1. doi: 10.3390/proteomes7010001.
1,2, 3,4, 5, 6, 7,8, 9,10
Ìý
2018 Nov 21;6:33. doi: 10.1186/s40364-018-0147-6. eCollection 2018.
1, 1, 2, 3, 4, 5, 6,7, 6,7, 6,7.
Ìý
2018 Oct;461:53-62. doi: 10.1016/j.jim.2018.06.003. Epub 2018 Jun 12.
1, 2, 3, 4.
Ìý
2018 Sep 23;2018:2045985. doi: 10.1155/2018/2045985. eCollection 2018.
1,2, 1, 1, 3, 4,5, 1,2, 1,2.
Ìý
2018 Sep 22;19(10). pii: E2886. doi: 10.3390/ijms19102886.
1,2, 3,4, 5, 6, 7, 8,9.
Ìý
2018 Sep 14;10(9). pii: E332. doi: 10.3390/cancers10090332.
1, 2,3, 4, 5,6, 7,8.
Ìý
2018 Aug 29. doi: 10.1111/vox.12703. [Epub ahead of print]
1, 2, 1,3, 2, 1,3, 4,5,6,7,8, 1,3.
Ìý
2018 Aug 20:1-3. doi: 10.1080/17474086.2018.1511420. [Epub ahead of print]
1,2, 3, 4, 2.
Ìý
2018 Jul 3;2018(7):omy038. doi: 10.1093/omcr/omy038. eCollection 2018 Jul.
1, 2, 3,4, 5, 5,6.
Ìý
2018 Jun 12. pii: S0022-1759(17)30510-0. doi: 10.1016/j.jim.2018.06.003. [Epub ahead of print]
1, 2, 3, 4.
Ìý
2018 Jun 7;8(2):1061. doi: 10.4081/cp.2018.1061. eCollection 2018 Mar 28.
1,2, 2, 1,3, 2, 1,2, 1,2.
Ìý
2018 Mar 7. doi: 10.1111/cei.13124. [Epub ahead of print]
1,2, 3, 1, 1, 4, 1,2.
Ìý
2018 May;20(5):740-754. doi: 10.1016/j.jcyt.2018.02.366. Epub 2018 Mar 22.
.
1, 2, 3, 4, 5, 5, 6, 5, 6.
Ìý
2018 Apr;27(4):377-387. doi: 10.1080/13543784.2018.1459562. Epub 2018 Apr 4.
1, 2, 1,3, 1,3, 1,3.
Ìý
2018 Apr 6;9:691. doi: 10.3389/fimmu.2018.00691. eCollection 2018.
1,2, 1,2, 2, 3, 4, 5, 1,2, 1,2.
Ìý
2018 Feb 28;2018:7697283. doi: 10.1155/2018/7697283. eCollection 2018.
1, 2, 1, 1,3, 1,3.
Ìý
2018 May 2;9:845. doi: 10.3389/fimmu.2018.00845. eCollection 2018.
1,2, 3, 4,5, 1,2, 2,6.
Ìý
2018 May 22;5:147. doi: 10.3389/fmed.2018.00147. eCollection 2018.
1, 1, 1, 1, 1,2, 1,2.
Ìý
2018 Jun 11. doi: 10.1080/14728222.2018.1487401. [Epub ahead of print]
1, 1,2, 3, 3, 1, 1, 3, 3, 1, 1, 1,4, 1,4.
Ìý
2018 Jan 27;19(2). pii: E382. doi: 10.3390/ijms19020382.
1, 2, 3,4, 5,6, 7,8.
Ìý
2018 Jan 24;8:1979. doi: 10.3389/fimmu.2017.01979. eCollection 2017.
1,2, 1,2, 1,2, 1, 2, 1,2.
Ìý
2018 Jan 19;19(1). pii: E296. doi: 10.3390/ijms19010296.
1,2, 3,4, 5, 6, 7, 8,9, 10,11.
Ìý
2018 Jan 15;19(1). pii: E251. doi: 10.3390/ijms19010251.
1, 2,3, 4, 5,6, 7,8.
2017
2017 Nov 21. pii: S1874-3919(17)30394-9. doi: 10.1016/j.jprot.2017.11.014. [Epub ahead of print]
1, 2, 3, 1, 4, 4, 5, 6.
Ìý
2017 Nov 23:1-12. doi: 10.1080/17474086.2018.1407239. [Epub ahead of print]
1,2, 1, 1,2, 1,3.
Ìý
2017 Oct;12(10):1053-1065. doi: 10.1080/17460441.2017.1356818. Epub 2017 Jul 27.
1,2, 1,3, 1,3, 2, 2.
Ìý
2017 Oct;143(10):1985-1998. doi: 10.1007/s00432-017-2458-7. Epub 2017 Jun 19.
1, 2,3, 1,4.
Ìý
2017 Sep 6;17(1):630. doi: 10.1186/s12885-017-3620-y.
1, 2, 3, 2, 3, 3, 3.
Ìý
2017 Aug;14(8):649-663. doi: 10.1080/14789450.2017.1352474. Epub 2017 Jul 27.
1,2, 3,4, 2, 2, 1.
Ìý
2017 Jun 8;8:667. doi: 10.3389/fimmu.2017.00667. eCollection 2017.
1,2, 3, 4, 1,2.
Ìý
2017 Jun;13(6):553-569. doi: 10.1080/1744666X.2017.1279053. Epub 2017 Jan 17.
1,2, 1, 1, 1, 1,2, 3.
Ìý
2017 Jun;58(6):1494-1497. doi: 10.1080/10428194.2016.1243682. Epub 2016 Oct 14.
1, 2, 2, 2, 2, 1,3.
Ìý
2017 Apr;21(4):357-369. doi: 10.1080/14728222.2017.1300255. Epub 2017 Mar 3.
1, 1, 1, 1, 1, 1,2, 1,2.
Ìý
2017 Mar 11;22(3). pii: E446. doi: 10.3390/molecules22030446.
1, 2, 3, 4, 5, 6,7.
Ìý
2017 Mar;26(3):343-355. doi: 10.1080/13543784.2017.1275564. Epub 2016 Dec 28.
1, 2, 1,2.
Ìý
2017 Feb 9;8:106. doi: 10.3389/fimmu.2017.00106. eCollection 2017.
1, 1, 2.
Ìý
2017 Jan 28;18(1):5. doi: 10.1186/s12865-017-0190-3.
1,2, 3,4, 3,5, 3, 3, 6, 3, 3,5.
Ìý
2017;13(1):2. Epub 2016 Nov 28.
1, 1, 2.
2016
2016;17(1):52-70.
, , , , 1.
Ìý
2016 Dec 10. doi: 10.18632/oncotarget.13853. [Epub ahead of print]
1, 2,3, 1,3, 1.
Ìý
2016 Dec 6;136(22):1889-1894. eCollection 2016 Dec.
[Article in English, Norwegian]
1, 2, 3, 4, 4, 5.
Ìý
2016 Dec 1;7(12):e2497. doi: 10.1038/cddis.2016.392.
1, 1, 2, 1, 3,4, 5, 5, 2,6, 7, 4,5, 4,5, 2, 1,4.
Ìý
2016;12(1):12. Epub 2015 Nov 16.
1, 2, 1.
Ìý
2016 Nov 1;17(11). pii: E1823.
1, 2, 3,4, 5, 6, 7, 8, 9,10.
Ìý
2016 Nov 11;21(11). pii: E1512.
1, 2,3, 4,5.
Ìý
2016 Sep;65(9):1135-47. doi: 10.1007/s00262-016-1865-y. Epub 2016 Aug 1.
1, 2, 1,3, 1,2, 4,5.
Ìý
2016 Aug 22;4(3). pii: E24. doi: 10.3390/proteomes4030024.
1, 2, 3, 4, 5.
Ìý
2016 Aug 11;145:214-25. doi: 10.1016/j.jprot.2016.03.049. Epub 2016 Apr 20.
1, 2, 3, 4, 5, 6, 7, 8.
Ìý
2016 Jul 19;17(7). pii: E1158. doi: 10.3390/ijms17071158.
1,2, 3, 4, 5, 6,7, 8,9, 10,11.
Ìý
2016 Jul 5;17(7). pii: E1080. doi: 10.3390/ijms17071080.
1,2, 3, 4, 5, 6,7.
Ìý
2016 Jun 21;18:13. doi: 10.1186/s12575-016-0043-0. eCollection 2016.
1, 1, 1, 1, 2, 1, 1.
Ìý
2015 Jun 24;5(2):e1062208. eCollection 2016 Feb.
1, 2, 3, 2, 2, 2, 2, 3, 3, 2, 3, 2.
Ìý
2016 May 25;7:205. doi: 10.3389/fimmu.2016.00205. eCollection 2016.
1, 2, 3.
Ìý
2016 Mar;96(3):211-21. doi: 10.1111/ejh.12690. Epub 2015 Nov 26.
1, 1,2, 1.
Ìý
2016 Feb;18(2):172-85. doi: 10.1016/j.jcyt.2015.11.010.
1, 2, 3, 4.
Ìý
2016 Jan 23. doi: 10.18632/oncotarget.6991. [Epub ahead of print]
1,2, 1, 1,2, 1, 1, 1, 1,3, 1,2,3, 1,3.
Ìý
2016;17(1):6-19.
1, , , , .
Ìý
2016;17(1):92-104.
, , 1.
Ìý
2016 Feb;18(2):172-85. doi: 10.1016/j.jcyt.2015.11.010.
1, 2, 3, 4.
Ìý
2016 Jan 23. doi: 10.18632/oncotarget.6991. [Epub ahead of print]
1,2, 1, 1,2, 1, 1, 1, 1,3, 1,2,3, 1,3.
2015
Ìý
2015;2015:943430. doi: 10.1155/2015/943430. Epub 2015 Nov 2.
1, 2, 2, 2, 1.
Ìý
2015 Oct 14. doi: 10.1111/ejh.12690. [Epub ahead of print]
1, 1,2, 1.
Ìý
2015 Sep 30. [Epub ahead of print]
, , 1.
Ìý
2015 Sep 25;15(3):530-541. doi: 10.1016/j.scr.2015.09.008. [Epub ahead of print]
1, 2, 2, 3, 4, 2, 5.
Ìý
2015 Sep 7. [Epub ahead of print]
1, , , , .
Ìý
2015 Jul;136(1):30-9. doi: 10.1016/j.thromres.2015.04.002. Epub 2015 Apr 11.
1, 2, 2, 3, 4.
Ìý
2015 Jun;26(4):469-72. doi: 10.1097/MBC.0000000000000255.
1, , , , .
Ìý
2015 Jun 9;11(9):1446-57. doi: 10.1016/j.celrep.2015.04.063. Epub 2015 May 21.
1, 1, 2, 2, 1, 1, 3, 4, 4, 2, 5, 1, 1, 1, 1, 3, 3, 2, 6, 6, 1, 1, 3, 2, 1, 7.
Ìý
2015 Jun;8(3):299-313. doi: 10.1586/17474086.2015.1032935. Epub 2015 Apr 3.
1, , , , .
Ìý
2015 Jun;8(3):315-27. doi: 10.1586/17474086.2015.1036025. Epub 2015 Apr 22.
1, , .
Ìý
2015 May 2;16:12. doi: 10.1186/s40360-015-0012-2.
1,2, 3, 4, 5, 6,7.
Ìý
2015 Mar;418:19-28. doi: 10.1016/j.jim.2015.01.006. Epub 2015 Jan 28.
1, 2, 3, 3, 4.
Ìý
2015 Mar;35(3):645-52. doi: 10.3892/ijmm.2014.2045. Epub 2014 Dec 19.
1, 1, 2, 1, 2, 1.
Ìý
2015 Feb 20;6(5):2794-811.
1,2, 1,2, 1,2, 2, 1, 1, 1, 3,4,5, 3,4,5, 1,2, 6,3,4,5.
Ìý
2015 Feb;8(1):29-41. doi: 10.1586/17474086.2015.971005. Epub 2014 Nov 6.
1, , , ,
2014
Ìý
J Immunol. 2014 Dec 15;193(12):6192-206. doi: 10.4049/jimmunol.1400859. Epub 2014 Nov 7.
Gras Navarro A1, Kmiecik J1, Leiss L2, Zelkowski M1, Engelsen A1, Bruserud Ø3, Zimmer J4, Enger PØ2, Chekenya M5.
Ìý
Molecules. 2014 Nov 12;19(11):18414-47. doi: 10.3390/molecules191118414.
Brenner AK1, Reikvam H1, Lavecchia A2, Bruserud Ø3.
Ìý
J Transplant. 2014;2014:404096. doi: 10.1155/2014/404096. Epub 2014 Oct 8.
Lindås R1, Tvedt TH1, Hatfield KJ2, Reikvam H1, Bruserud O3.
Ìý
Cell Stem Cell. 2014 Oct 2;15(4):431-46. doi: 10.1016/j.stem.2014.08.001.
Li L1, Osdal T2, Ho Y1, Chun S1, McDonald T1, Agarwal P1, Lin A1, Chu S1, Qi J1, Li L1, Hsieh YT1, Dos Santos C1, Yuan H3, Ha TQ2, Popa M4, Hovland R5, Bruserud O6, Gjertsen BT6, Kuo YH1, Chen W3, Lain S7, McCormack E8, Bhatia R9.
Ìý
Springerplus. 2014 Sep 30;3:571. doi: 10.1186/2193-1801-3-571. eCollection 2014.
Mosevoll KA1, Lindås R2, Wendelbo O3, Bruserud O4, Reikvam H2.
Ìý
Expert Opin Ther Targets. 2014 Sep 9:1-15. [Epub ahead of print]
Hatfield KJ, Reikvam H, Bruserud O.
Ìý
Ìý
Proteomics. 2014 Sep;14(17-18):1971-6. doi: 10.1002/pmic.201300448. Epub 2014 Aug 8.
Aasebø E, Vaudel M, Mjaavatten O, Gausdal G, Van der Burgh A, Gjertsen BT, Døskeland SO, Bruserud O, Berven FS, Selheim F.
Ìý
Cancer Immunol Immunother. 2014 Aug;63(8):757-77. doi: 10.1007/s00262-014-1578-z. Epub 2014 Jul 5.
Bruserud Ø, Tvedt TH, Paulsen PQ, Ahmed AB, Gedde-Dahl T, Tjønnfjord GE, Slåstad H, Heldal D, Reikvam H.
Ìý
Expert Opin Ther Targets. 2014 Aug;18(8):929-44. doi: 10.1517/14728222.2014.924925. Epub 2014 Jun 24.
Reikvam H, Brenner AK, Nepstad I, Sulen A, Bruserud Ø.
Ìý
Oncoscience. 2014 Aug 6;1(8):529-39. eCollection 2014.
Hampson P1, Wang K2, Ersvær E3, McCormack E3, Schüler J4, Fiebig HH4, Gjertsen BT3, Bruserud Ø3, Lord JM1.
Ìý
Ìý
Tidsskrift for den Norske laegeforening 2014 May 27;134:1052-5. Norwegian.
Reikvam H, Hovland R, Bruserud O.
Ìý
Tidsskr Nor Laegeforen. 2014 May 27;134(10):1058-61. doi: 10.4045/tidsskr.13.0817. eCollection 2014.
Ìý [Article in Norwegian]
Tvedt TH, Holme PA, Bruserud Ø.
Ìý
Mol Cancer. 2014 May 21;13:116. doi: 10.1186/1476-4598-13-116.
Haaland I, Opsahl JA, Berven FS, Reikvam H, Fredly HK, Haugse R, Thiede B, McCormack E, Lain S, Bruserud O, Gjertsen BT.
Ìý
Leukemia. 2014 Feb 27. doi: 10.1038/leu.2014.89. [Epub ahead of print]
Kontro M, Kuusanmäki H, Eldfors S, Burmeister T, Andersson EI, Bruserud O, Brümmendorf TH, Edgren H, Gjertsen BT, Itälä-Remes M, Lagsrtöm S, Lohi O, Lundán T, Martà JM, Majumder MM, Parsons A, Pemovska T, Rajala H, Vettenranta K, Kallioniemi O, Mustjoki S, Porkka K, Heckman CA.
Ìý
Ìý
Leuk Res Treatment. 2014;2014:143479. doi: 10.1155/2014/143479. Epub 2014 Jan 8.
Kvestad H, Evensen L, Lorens JB, Bruserud O, Hatfield KJ.
Ìý
Ìý
Br J Haematol. 2014 Jan;164(2):200-11. doi: 10.1111/bjh.12611. Epub 2013 Oct 23.
Reikvam H, Tamburini J, Skrede S, Holdhus R, Poulain L, Ersvaer E, Hatfield KJ, Bruserud O.
Ìý
Ìý
Blood Transfus. 2013 Oct 24:1-6. doi: 10.2450/2013.0303-12. [Epub ahead of print]
Nepstad I, Reikvam H, Strandenes G, Hess JR, Apelseth TO, Hervig TA.
2013
Ìý
Expert Opin Investig Drugs. 2013 Nov;22(11):1365-70. doi: 10.1517/13543784.2013.841137. Epub 2013 Oct 7.
Reikvam H, Nepstad I, Tamburini J.
Ìý
Cell Prolif. 2013 Oct;46(5):554-62. doi: 10.1111/cpr.12057.
Reikvam H, Øyan AM, Kalland KH, Hovland R, Hatfield KJ, Bruserud Ø.
Ìý
Oncotarget. 2013 Sep;4(9):1438-48.
Astori A, Fredly H, Aloysius TA, Bullinger L, Mansat-De Mas V, de la Grange P, Delhommeau F, Hagen KM, Récher C, Dusanter-Fourt I, Knappskog S, Lillehaug JR, Pendino F, Bruserud Ø.
Ìý
Oncotarget. 2013 Jun;4(6):830-43.
Reikvam H, Nepstad I, Bruserud Ø, Hatfield KJ.
Ìý
Transfus Med. 2013 Dec;23(6):397-406. doi: 10.1111/tme.12067. Epub 2013 Aug 6.
Bruserud O, Liseth K, Stamnesfet S, Cacic DL, Melve G, Kristoffersen E, Hervig T, Reikvam H.
Ìý
Clin Epigenetics. 2013 Aug 1;5(1):13. doi: 10.1186/1868-7083-5-13.
Fredly H, Ersvær E, Kittang AO, Tsykunova G, Gjertsen BT, Bruserud O.
Ìý
Clin Epigenetics. 2013 Jul 30;5(1):12. doi: 10.1186/1868-7083-5-12.
Fredly H, Gjertsen BT, Bruserud O.
Ìý
BMC Pharmacol Toxicol. 2013 Jul 11;14:35. doi: 10.1186/2050-6511-14-35.
Bredholt T, Ersvær E, Erikstein BS, Sulen A, Reikvam H, Aarstad HJ, Johannessen AC, Vintermyr OK, Bruserud Ø, Gjertsen BT.
Ìý
Cytotherapy. 2013 Apr 24. pii: S1465-3249(13)00409-X. doi: 10.1016/j.jcyt.2013.02.008. [Epub ahead of print]
Mosevoll KA, Akkök CA, Hervig T, Melve GK, Bruserud O, Reikvam H.
Ìý
Expert Opin Investig Drugs. 2013 May;22(5):551-63. doi: 10.1517/13543784.2013.791280.
Reikvam H, Nepstad I, Sulen A, Gjertsen BT, Hatfield KJ, Bruserud Ø.
Ìý
Oncoimmunology. 2013 Feb 1;2(2):e23138.
Sand KE, Rye KP, Mannsåker B, Bruserud O, Kittang AO.
Ìý
Cell Death Dis. 2013 Feb 28;4:e516. doi: 10.1038/cddis.2013.39.
Gausdal G, Wergeland A, Skavland J, Nguyen E, Pendino F, Rouhee N, McCormack E, Herfindal L, Kleppe R, Havemann U, Schwede F, Bruserud O, Gjertsen BT, Lanotte M, Ségal-Bendirdjian E, Døskeland SO.
Ìý
Blood. 2013 Feb 14;121(7):e34-42. doi: 10.1182/blood-2012-05-429555. Epub 2012 Dec 12.
McCormack E, Mujić M, Osdal T, Bruserud Ø, Gjertsen BT.
Ìý
Oncoimmunology. 2013 Feb 1;2(2):e23138.
Sand KE, Rye KP, Mannsåker B, Bruserud O, Kittang AO.
Ìý
Toxins (Basel). 2013 Feb 18;5(2):336-62. doi: 10.3390/toxins5020336.
Reikvam H, Fredly H, Kittang AO, Bruserud O.
Ìý
Mar Drugs. 2013 Jan 30;11(2):332-49. doi: 10.3390/md11020332.
Myhren LE, Nygaard G, Gausdal G, Sletta H, Teigen K, Degnes KF, Zahlsen K, Brunsvik A, Bruserud O, Døskeland SO, Selheim F, Herfindal L.
Ìý
Curr Cancer Drug Targets. 2013 Jan;13(1):30-47.
Reikvam H, Kittang AO, Melve G, Mosevoll KA, Bentsen PT, Ersvær E, Gjertsen BT, Bruserud Ø.
2012
Ìý
Eur Cytokine Netw. 2012 Nov 1;23(4):140-53. doi: 10.1684/ecn.2012.0322.
Reikvam H, Hatfield KJ, Fredly H, Nepstad I, Mosevoll KA, Bruserud O.
Ìý
Blood. 2013 Feb 14;121(7):e34-42. doi: 10.1182/blood-2012-05-429555. Epub 2012 Dec 12.
McCormack E, Mujic M, Osdal T, Bruserud O, Gjertsen BT.
Ìý
Bone Marrow Res. 2012;2012:329061. doi: 10.1155/2012/329061. Epub 2012 Oct 2.
Ryningen A, Reikvam H, Nepstad I, Paulsen Rye K, Bruserud O.
Ìý
Cancer Chemother Pharmacol. 2012 Oct 6. [Epub ahead of print]
Bruserud O, Reikvam H, Kittang AO, Ahmed AB, Tvedt TH, Sjo M, Hatfield KJ.
Ìý
Eur J Haematol. 2012 Oct 9. doi: 10.1111/ejh.12016. [Epub ahead of print]
Hatfield KJ, Evensen L, Reikvam H, Lorens JB, Bruserud O.
Ìý
Curr Cancer Drug Targets. 2012 Aug 2. [Epub ahead of print]
Reikvam H, Kittang AO, Melve G, Mosevoll KA, Bentsen PT, Ersvær E, Gjertsen BT, Bruserud O.
Ìý
Blood. 2012 Jul 26;120(4):847-57. Epub 2012 Jun 12.
Lång E, Grudic A, Pankiv S, Bruserud O, Simonsen A, Bjerkvig R, Bjørås M, Bøe SO.
Ìý
Expert Opin Investig Drugs. 2012 May;21(5):587-603. Epub 2012 Mar 17.
Tsykunova G, Reikvam H, Ahmed AB, Nepstad I, Gjertsen BT, Bruserud O.
Ìý
Leukemia. 2012 Apr;26(4):563-71. doi: 10.1038/leu.2011.314. Epub 2011 Nov 11.
Reikvam H, Tiu RV.
Ìý
Am J Hematol. 2012 Apr;87(4):368-76. doi: 10.1002/ajh.23116. Epub 2012 Feb 28.
Fredly H, Reikvam H, Gjertsen BT, Bruserud O.
Ìý
Br J Haematol. 2012 Feb;156(4):468-80. doi: 10.1111/j.1365-2141.2011.08960.x. Epub 2011 Dec 13.
Reikvam H, Hatfield KJ, Ersvaer E, Hovland R, Skavland J, Gjertsen BT, Petersen K, Bruserud O.
Ìý
Leukemia. 2012 May;26(5):910-7. doi: 10.1038/leu.2011.315. Epub 2011 Nov 8.
McCormack E, Haaland I, Venås G, Forthun RB, Huseby S, Gausdal G, Knappskog S, Micklem DR, Lorens JB, Bruserud O, Gjertsen BT.
Ìý
Biol Blood Marrow Transplant. 2012 Feb;18(2):190-9. doi: 10.1016/j.bbmt.2011.10.007. Epub 2011 Oct 20.
Reikvam H, Mosevoll KA, Melve GK, Günther CC, Sjo M, Bentsen PT, Bruserud Ø.
Ìý
Leukemia. 2012 Mar;26(3):557-9. doi: 10.1038/leu.2011.243. Epub 2011 Sep 9.
Tsykunova G, Reikvam H, Hovland R, Bruserud Ø.
Ìý
Oncogene. 2012 Mar 22;31(12):1533-45. doi: 10.1038/onc.2011.348. Epub 2011 Aug 22.
Ånensen N, Hjelle SM, Van Belle W, Haaland I, Silden E, Bourdon JC, Hovland R, Taskén K, Knappskog S, Lønning PE, Bruserud Ø, Gjertsen BT.
2011
Ìý
Leukemia. 2012 Apr;26(4):563-71. doi: 10.1038/leu.2011.314. Epub 2011 Nov 11.
Reikvam H, Tiu RV.
Ìý
Hematology. 2011 Nov;16(6):351-6.
Hatfield KJ, Lassalle P, Leiva RA, Lindås R, Wendelboe Ø, Bruserud Ø.
Ìý
Bone Marrow Res. 2011;2011:570796. Epub 2010 Oct 4.
Ersvaer E, Hatfield KJ, Reikvam H, Bruserud O.
Ìý
Biol Blood Marrow Transplant. 2012 Feb;18(2):190-9. Epub 2011 Oct 20.
Reikvam H, Mosevoll KA, Melve GK, Günther CC, Sjo M, Bentsen PT, Bruserud Ø.
Ìý
J Infect Dis. 2011 Dec;204(11):1779-86. Epub 2011 Oct 11.
Hanevik K, Kristoffersen E, Svard S, Bruserud O, Ringqvist E, Sørnes S, Langeland N.
Ìý
Cancer Immunol Immunother. 2011 Dec;60(12):1669-81. Epub 2011 Oct 12.
Ersvær E, Melve GK, Bruserud O.
Ìý
Expert Rev Hematol. 2011 Oct;4(5):563-76.
Melve GK, Ersvssr E, Kittang AO, Bruserud O.
Ìý
Cytotherapy. 2011 Nov;13(10):1259-68. doi: 10.3109/14653249.2011.605117. Epub 2011 Sep 12.
Akkök CA, Hervig T, Stamnesfet S, Nesthus I, Melve GK, Lassalle P, Bruserud O.
Ìý
Leuk Res. 2011 Sep;35(9):1156-8. Epub 2011 Jul 30.
Bruserud Ø, Hatfield KJ, Reikvam H.
Ìý
J Biomed Biotechnol. 2011;2011:104631. Epub 2011 May 3.
Reikvam H, Hatfield KJ, Kittang AO, Hovland R, Bruserud Ø.
Ìý
Cytotherapy. 2011 Sep;13(8):1013-24. Epub 2011 Apr 20.
Akkök CA, Liseth K, Melve GK, Ersvaer E, Hervig T, Bruserud Ø.
Ìý
Oncol Rep. 2011 Jun;25(6):1549-56. doi: 10.3892/or.2011.1229. Epub 2011 Mar 22.
Fredly H, Ersvær E, Gjertsen BT, Bruserud O.
Ìý
Eur Cytokine Netw. 2011 Mar;22(1):52-62.
Apelseth TO, Hervig T, Wentzel-Larsen T, Petersen K, Reikvam H, Bruserud Ø.
Ìý
Blood Rev. 2011 May;25(3):113-22. Epub 2011 Feb 12.
Apelseth TO, Hervig T, Bruserud O.
Ìý
Blood Cancer J. 2011 Feb;1(2):e4. doi: 10.1038/bcj.2011.2. Epub 2011 Feb 11.
Skavland J, Jørgensen KM, Hadziavdic K, Hovland R, Jonassen I, Bruserud O, Gjertsen BT.
Ìý
J Proteomics. 2011 Mar 1;74(3):269-81. Epub 2010 Nov 12.
Jørgensen KM, Hjelle SM, Øye OK, Puntervoll P, Reikvam H, Skavland J, Anderssen E, Bruserud Ø, Gjertsen BT.
2010
Ìý
Curr Med Chem. 2010;17(36):4448-61.
Hatfield KJ, Reikvam H, Bruserud Ø.
Ìý
Curr Top Microbiol Immunol. 2010;341:v-vi.
Bruserud Ø.
Ìý
Expert Opin Ther Targets. 2010 Nov;14(11):1139-42.
Bruserud Ø, Reikvam H.
Ìý
Hematology. 2010 Oct;15(5):338-43.
Fredly H, Stapnes Bjørnsen C, Gjertsen BT, Bruserud Ø.
Ìý
Blood. 2010 Sep 2;116(9):1389-90.
Bruserud O, Hatfield K.
Ìý
Eur Cytokine Netw. 2010 Sep;21(3):154-64. Epub 2010 Aug 20.
Hatfield KJ, Bedringsaas SL, Ryningen A, Gjertsen BT, Bruserud O.
Ìý
Leuk Res. 2010 Nov;34(11):1422-3. Epub 2010 Jul 16.
Bruserud Ø, Reikvam H.
Ìý
J Biomed Biotechnol. 2010;2010:692097. Epub 2010 Jun 2.
Liseth K, Ersvaer E, Hervig T, Bruserud Ø.
Ìý
BMC Immunol. 2010 Jul 9;11:38.
Ersvaer E, Liseth K, Skavland J, Gjertsen BT, Bruserud Ø.
Ìý
Genome Med. 2010 Jun 29;2(6):41.
Hjelle SM, Forthun RB, Haaland I, Reikvam H, Sjøholt G, Bruserud O, Gjertsen BT.
Ìý
Nutr Cancer. 2010;62(5):574-83.
McCormack E, Skavland J, Mujic M, Bruserud Ø, Gjertsen BT.
Ìý
Transfus Apher Sci. 2010 Aug;43(1):33-6. Epub 2010 Jun 16.
Akkök CA, Hervig T, Bjørsvik S, Underdal MO, Skoug CF, Ersvaer E, Bruserud Ø.
Ìý
Apoptosis. 2010 Aug;15(8):946-55.
Hampson P, Wang K, Milverton L, Ersvaer E, Bruserud O, Lord JM.
Ìý
Curr Top Microbiol Immunol. 2010;341:149-72.
Kittang AO, Hatfield K, Sand K, Reikvam H, Bruserud Ø.
Ìý
Curr Top Microbiol Immunol. 2010;341:3-12.
Bruserud Ø, Kittang AO.
Ìý
Eur Cytokine Netw. 2010 Mar;21(1):40-9.
Liseth K, Sjo M, Paulsen K, Bruserud Ø, Ersvaer E.
Ìý
Expert Opin Investig Drugs. 2010 Feb;19(2):169-83.
Reikvam H, Hatfield KJ, Lassalle P, Kittang AO, Ersvaer E, Bruserud Ø.
Ìý
Toxins (Basel). 2010 Jan;2(1):174-94. Epub 2010 Jan 22.
Ersvaer E, Kittang AO, Hampson P, Sand K, Gjertsen BT, Lord JM, Bruserud O.
Ìý
Transfusion. 2010 Apr;50(4):766-75. Epub 2009 Dec 18.
Apelseth TO, Bruserud O, Wentzel-Larsen T, Hervig T.
Ìý
Eur J Haematol. 2010 Mar;84(3):239-51. Epub 2009 Nov 17.
Reikvam H, Hatfield KJ, Oyan AM, Kalland KH, Kittang AO, Bruserud O.
Ìý
Biochim Biophys Acta. 2010 Jan;1798(1):1-8. Epub 2009 Oct 31.
Foss B, Tronstad KJ, Bruserud Ø.
2009
Ìý
Crit Rev Oncog. 2009;15(1-2):1-41.
Reikvam H, Olsnes AM, Gjertsen BT, Ersvar E, Bruserud Ø.
Ìý
J BUON. 2009 Sep;14 Suppl 1:S131-40.
Olsnes AM, Hatfield KJ, Bruserud Ø.
Ìý
Crit Rev Oncog. 2009;15(1):1-36.
Nuclear Factor-kappaB Signaling: A Contributor in Leukemogenesis and a Target for Pharmacological Intervention in Human Acute Myelogenous Leukemia.
Reikvam H, Olsnes AM, Gjertsen BT, Ersvar E, Bruserud O.
Ìý
Cytotherapy. 2009;11(6):749-60.
Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
Akkök CA, Liseth K, Hervig T, Ryningen A, Bruserud Ø, Ersvaer E.
Ìý
Curr Cancer Drug Targets. 2009 Sep;9(6):761-76.
Reikvam H, Ersvaer E, Bruserud O.
Ìý
Hematology. 2009 Aug;14(4):224-6. doi: 10.1179/102453309X439782.
Bruserud Ø, Håvardstein K.
Ìý
Transfusion. 2009 Aug;49(8):1709-19.
Liseth K, Ersvær E, Abrahamsen JF, Nesthus I, Ryningen A, Bruserud Ø.
Ìý
Br J Haematol. 2009 Jun;145(6):761-74. Epub 2009 Apr 20.
Olsnes AM, Ersvaer E, Ryningen A, Paulsen K, Hampson P, Lord JM, Gjertsen BT, Kristoffersen EK, Bruserud Ø.
Ìý
Stem Cells Dev. 2009 Jul-Aug;18(6):807-12.
Foss B, Hervig T, Bruserud O.
Ìý
Expert Opin Investig Drugs. 2009 Apr;18(4):433-55.
Stapnes C, Gjertsen BT, Reikvam H, Bruserud Ø.
Ìý
BMC Cancer. 2009 Mar 5;9:77.
Øyan AM, Anensen N, Bø TH, Stordrange L, Jonassen I, Bruserud Ø, Kalland KH, Gjertsen BT.
Ìý
Tidsskr Nor Laegeforen. 2009 Feb 26;129(5):416-9.
[Granulocyte transfusion]. [Article in Norwegian]
Reikvam H, Blom US, Kristoffersen E, Liseth K, Bruserud O, Hervig T.
Ìý
Br J Haematol. 2009 Jan;144(1):53-68. Epub 2008 Oct 30.
Hatfield K, Øyan AM, Ersvaer E, Kalland KH, Lassalle P, Gjertsen BT, Bruserud Ø.
Ìý
Leuk Res. 2009 Jun;33(6):779-87. Epub 2008 Nov 12.
Ryningen A, Stapnes C, Lassalle P, Corbascio M, Gjertsen BT, Bruserud O.
Ìý
Transfusion. 2009 Feb;49(2):354-61. Epub 2008 Oct 28.
Akkök CA, Holte MR, Tangen JM, Ostenstad B, Bruserud O.
2008
Ìý
Curr Cancer Drug Targets. 2008 Dec;8(8):666-75.
Bruserud Ø, Ersvaer E, Olsnes A, Gjertsen BT.
Ìý
Hematology. 2008 Dec;13(6):329-32.
Olsnes AM, Ersvaer E, Ryningen A, Bruserud O.
Ìý
Expert Opin Investig Drugs. 2008 Nov;17(11):1623-33.
Ryningen A, Stapnes C, Paulsen K, Lassalle P, Gjertsen BT, Bruserud O.
Ìý
J Interferon Cytokine Res. 2008 May;28(5):297-310.
Olsnes AM, Ryningen A, Ersvaer E, Bruserud Ø.
Ìý
Transfusion. 2008 May;48(5):877-83. Epub 2008 Feb 21.
Akkök CA, Liseth K, Nesthus I, Løkeland T, Tefre K, Bruserud O, Abrahamsen JF.
Ìý
Platelets. 2008 Mar;19(2):155-9.
Foss B, Bruserud O, Hervig T.
Ìý
Oncogene. 2008 Jun 19;27(27):3765-79. doi: 10.1038/onc.2008.16. Epub 2008 Feb 11.
McCormack E, Bruserud O, Gjertsen BT.
Ìý
Thromb Haemost. 2008 Jan;99(1):27-37.
Foss B, Bruserud O.
Ìý
Blood. 2008 Mar 1;111(5):2866-77. Epub 2008 Jan 8.
Gausdal G, Gjertsen BT, McCormack E, Van Damme P, Hovland R, Krakstad C, Bruserud Ø, Gevaert K, Vandekerckhove J, Døskeland SO.
Ìý
Leukemia. 2008 Feb;22(2):287-93. Epub 2007 Oct 18.
Hatfield KJ, Hovland R, Øyan AM, Kalland KH, Ryningen A, Gjertsen BT, Bruserud Ø.
2007
Ìý
Curr Pharm Biotechnol. 2007 Dec;8(6):401-11.
Ryningen A, Bruserud Ø.
Ìý
Curr Pharm Biotechnol. 2007 Dec;8(6):344-54.
Oyan AM, Bø TH, Jonassen I, Ulvestad E, Tore Gjertsen B, Bruserud O, Kalland KH.
Ìý
Curr Pharm Biotechnol. 2007 Dec;8(6):318-9.
Bruserud O.
Ìý
Int J Oncol. 2007 Dec;31(6):1529-38.
Stapnes C, Ryningen A, Hatfield K, Øyan AM, Eide GE, Corbascio M, Kalland KH, Gjertsen BT, Bruserud Ø.
Ìý
Expert Opin Ther Targets. 2007 Aug;11(8):1055-69.
Hagland H, Nikolaisen J, Hodneland LI, Gjertsen BT, Bruserud Ø, Tronstad KJ.
Ìý
Eur J Haematol. 2007 Sep;79(3):210-25. Epub 2007 Jul 26.
Ersvaer E, Zhang JY, McCormack E, Olsnes A, Anensen N, Tan EM, Gjertsen BT, Bruserud O.
Ìý
Hematology. 2007 Jun;12(3):199-207.
Ersvaer E, Hampson P, Wendelbo Ø, Lord JM, Gjertsen BT, Bruserud Ø.
Ìý
Mol Cancer. 2007 May 11;6:33.
Wergeland L, Sjøholt G, Haaland I, Hovland R, Bruserud Ø, Gjertsen BT.
Ìý
Expert Rev Anticancer Ther. 2007 May;7(5):741-51.
Anensen N, Øyan AM, Huseby S, Kalland KH, Bruserud Ø, Gjertsen BT.
Ìý
Mol Cancer. 2007 Apr 23;6:31.
Huang TS, Myklebust LM, Kjarland E, Gjertsen BT, Pendino F, Bruserud Ø, Døskeland SO, Lillehaug JR.
Ìý
Anal Biochem. 2007 Jul 1;366(1):46-58. Epub 2007 Mar 18.
Petersen K, Oyan AM, Rostad K, Olsen S, Bø TH, Salvesen HB, Gjertsen BT, Bruserud O, Halvorsen OJ, Akslen LA, Steen VM, Jonassen I, Kalland KH.
Ìý
Leuk Res. 2007 Sep;31(9):1303-13. Epub 2007 Apr 9.
Ryningen A, Stapnes C, Bruserud Ø.
Ìý
Transfusion. 2007 Apr;47(4):653-65.
Apelseth TØ, Bruserud Ø, Wentzel-Larsen T, Bakken AM, Bjørsvik S, Hervig T.
Ìý
Br J Haematol. 2007 Mar;136(6):814-28.
Stapnes C, Døskeland AP, Hatfield K, Ersvaer E, Ryningen A, Lorens JB, Gjertsen BT, Bruserud O.
Ìý
Haematologica. 2007 Mar;92(3):332-41.
Bruserud Ø, Ryningen A, Olsnes AM, Stordrange L, Øyan AM, Kalland KH, Gjertsen BT.
Ìý
Cancer Immunol Immunother. 2007 Jun;56(6):913-25. Epub 2006 Nov 8.
Ersvaer E, Hampson P, Hatfield K, Ulvestad E, Wendelbo Ø, Lord JM, Gjertsen BT, Bruserud Ø.
Ìý
Blood. 2007 Mar 15;109(6):2589-96. Epub 2006 Nov 14.
Irish JM, Anensen N, Hovland R, Skavland J, Børresen-Dale AL, Bruserud O, Nolan GP, Gjertsen BT.
Ìý
Cancer Immunol Immunother. 2007 Jan;56(1):13-24. Epub 2006 Apr 13.
Ersvaer E, Skavland J, Ulvestad E, Gjertsen BT, Bruserud Ø.
2006
Ìý
Platelets. 2006 Aug;17(5):296-302.
Ryningen A, Apelseth T, Hausken T, Bruserud Ø.
Ìý
Int J Cancer. 2006 Nov 15;119(10):2313-21.
Hatfield K, Ryningen A, Corbascio M, Bruserud O.
Ìý
Clin Cancer Res. 2006 Jul 1;12(13):3985-92.
Anensen N, Oyan AM, Bourdon JC, Kalland KH, Bruserud O, Gjertsen BT.
Ìý
Transfusion. 2006 May;46(5):800-10.
Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O.
Ìý
Acta Oncol. 2006;45(3):346-9.
Stapnes C, Ryningen A, Gjertsen BT, Bruserud Ø.
Ìý
Cancer. 2006 Jun 1;106(11):2397-405.
Samuelsson J, Hasselbalch H, Bruserud O, Temerinac S, Brandberg Y, Merup M, Linder O, Bjorkholm M, Pahl HL, Birgegard G; Nordic Study Group for Myeloproliferative Disorders.
Ìý
Cancer Immunol Immunother. 2007 Jan;56(1):13-24. Epub 2006Apr 13.
Ersvaer E, Skavland J, Ulvestad E, Gjertsen BT, Bruserud Ø.
Ìý
BMC Bioinformatics. 2006 Apr 10;7:198.
Van Belle W, Anensen N, Haaland I, Bruserud Ø, Høgda KA, Gjertsen BT.
Ìý
Leuk Res. 2006 Dec;30(12):1531-40. Epub 2006 Apr 5.
Ryningen A, Ersvaer E, Øyan AM, Kalland KH, Vintermyr OK, Gjertsen BT, Bruserud Ø.
Ìý
Int J Oncol. 2006 May;28(5):1065-80.
Øyan AM, Bø TH, Jonassen I, Gjertsen BT, Bruserud Ø, Kalland KH.
Ìý
Expert Opin Ther Targets. 2006 Feb;10(1):51-68.
Bruserud Ø, Stapnes C, Tronstad KJ, Ryningen A, Anensen N, Gjertsen BT.
Ìý
Leukemia. 2006 Apr;20(4):734-6.
Anensen N, Skavland J, Stapnes C, Ryningen A, Børresen-Dale AL, Gjertsen BT, Bruserud Ø.
Ìý
Cancer Immunol Immunother. 2006 Jul;55(7):830-40. Epub 2005 Nov 3.
Olsnes AM, Motorin D, Ryningen A, Zaritskey AY, Bruserud Ø.
Ìý
Cancer Immunol Immunother. 2006 Feb;55(2):221-8. Epub 2005 Jul 21.
Bruserud Ø, Tronstad KJ, McCormack E, Gjertsen BT.
Ìý
Cancer Immunol Immunother. 2006 Feb;55(2):185-7. Epub 2005 Jul 7.
Immunotherapy in chronic lymphocytic leukemia.
Bruserud Ø, McCormack E, Gjertsen BT.
2005
Ìý
Scand J Clin Lab Invest. 2005;65(6):505-11.
Bruserud O, Grovan F, Lindås R, Blymke Møinichen C, Osterhus KK.
Ìý
Curr Drug Targets. 2005 Sep;6(6):631-46.
Sjøholt G, Anensen N, Wergeland L, Mc Cormack E, Bruserud Ø, Gjertsen BT.
Ìý
Cytotherapy. 2005;7(4):328-33.
Liseth K, Abrahamsen JF, Bjørsvik S, Grøttebø K, Bruserud Ø.
Ìý
Curr Cancer Drug Targets. 2005 Jun;5(4):229-48.
Hatfield KJ, Olsnes AM, Gjertsen BT, Bruserud Ø.
Ìý
J Cancer Res Clin Oncol. 2005 Jun;131(6):377-84. Epub 2005 Mar 18.
Bruserud O, Tronstad KJ, Berge R.
Ìý
Cytometry B Clin Cytom. 2005 Mar;64(1):18-27.
Oyan AM, Bø TH, Jonassen I, Ulvestad E, Gjertsen BT, Kalland KH, Bruserud O.
Ìý
Transfusion. 2005 Feb;45(2):248-53.
Abrahamsen JF, Stamnesfet S, Liseth K, Hervig T, Bruserud O.
Ìý
Eur J Haematol. 2005 Jan;74(1):24-34.
Glenjen NI, Hatfield K, Bruserud Ø.
Ìý
Leuk Res. 2005 Feb;29(2):185-96.
Ryningen A, Wergeland L, Glenjen N, Gjertsen BT, Bruserud O.
2004
Ìý
Cytotherapy. 2004;6(4):356-62.
Abrahamsen JF, Wentzel-Larsen T, Bruserud O.
Ìý
Eur J Haematol. 2004 Nov;73(5):340-50.
Bruserud Ø, Wendelbo Ø, Paulsen K.
Ìý
Int J Cancer. 2004 Oct 10;111(6):858-67.
Glenjen N, Ersvaer E, Ryningen A, Bruserud Ø.
Ìý
Cell. 2004 Jul 23;118(2):217-28.
Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud Ø, Gjertsen BT, Nolan GP.
Ìý
Scand J Immunol. 2004 Jul-Aug;60(1-2):189-98.
Ersvaer E, Bertelsen LT, Espenes LC, Bredholt T, Bøe SO, Iversen BM, Bruserud Ø, Ulvestad E, Gjertsen BT.
Ìý
Cancer Immunol Immunother. 2004 Aug;53(8):740-7. Epub 2004 May 5.
Wendelbo Ø, Nesthus I, Sjo M, Paulsen K, Ernst P, Bruserud Ø.
Ìý
Transfusion. 2004 May;44(5):785-9.
Abrahamsen JF, Rusten L, Bakken AM, Bruserud Ø.
Ìý
Haematologica. 2004 Apr;89(4):391-402.
Bruserud Ø, Ryningen A, Wergeland L, Glenjen NI, Gjertsen BT.
Ìý
Cancer Immunol Immunother. 2004 Aug;53(8):677-80. Epub 2004 Apr 7.
Gjertsen BT, Bruserud Ø.
Ìý
Leuk Res. 2004 May;28(5):461-8.
Wendelbo Ø, Nesthus I, Sjo M, Ernst P, Bruserud Ø.
2003
Ìý
J Hematother Stem Cell Res. 2003 Oct;12(5):525-35.
Wendelbo Ø, Bruserud Ø.
Ìý
Hematology. 2003 Oct;8(5):313-8.
Motorin D, Bakken A, Foss Abrahamsen J, Ernst P, Bruserud Ø.
Ìý
Expert Opin Ther Targets. 2003 Oct;7(5):663-77.
Tronstad KJ, Berge K, Berge RK, Bruserud Ø.
Ìý
Eur J Haematol. 2003 Sep;71(3):163-73.
Glenjen N, Hovland R, Wergeland L, Wendelbo Ø, Ernst P, Bruserud Ø.
Ìý
J Hematother Stem Cell Res. 2003 Jun;12(3):351-8.
Bakken AM, Bruserud O, Abrahamsen JF.
Ìý
Eur J Haematol. 2003 Jul;71(1):9-17.
Bruserud Ø, Glenjen N, Ryningen A.
Ìý
Haematologica. 2003 Apr;88(4):416-28.
Bruserud Ø, Hovland R, Wergeland L, Huang TS, Gjertsen BT.
Ìý
Cancer Immunol Immunother. 2003 Apr;52(4):215-25. Epub 2003 Feb 15.
Bruserud O, Ulvestad E.
Ìý
Leuk Res. 2003 May;27(5):455-64.
Bruserud Ø, Glenjen N, Ryningen A, Ulvestad E.